My Assay

Only available on StudyMode
  • Topic: GlaxoSmithKline, Beecham, FTSE 100 Index
  • Pages : 6 (1499 words )
  • Download(s) : 119
  • Published : January 29, 2013
Open Document
Text Preview
2011
Most Respected Company Award - Business World
Launches Votrient™ indicated for the treatment of advanced renal cell carcinoma (RCC) Launches Revolade™ indicated for the treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP) Vaccine Market Company of the Year award - Frost & Sullivan Special Commendation - Good Corporate Citizen Award 2011 - Bombay Chamber of Commerce Pharma / Life - Science Supply Chain Excellence Award presented at the 5thExpress, Logistics and Supply Chain Conclave Unveils Synflorix - a vaccine against invasive pneumococcal disease 2012

Launches Altargo™ used to treat bacterial infections affecting small areas of skin Introduces Volibris (Ambrisentan), a non-sulphonamide class endothelin receptor antagonist (ERA) used to treat pulmonary arterial hypertension (PAH) indicated for WHO Functional Class II & III patients in India. Volibris® is a trademark of GlaxoSmithKline. Ambrisentan has been licensed to GlaxoSmithKline by Gilead Sciences Inc. 2001

Merger of SmithKline Beecham Pharmaceuticals (India) Limited into Glaxo India Limited. The name of the company changed to GlaxoSmithKline Pharmaceuticals Limited in India 2002
J P Garnier inaugurates GSK House
VRS at the Ankleshwar site and sale of Ankleshwar property to Glenmark Pharmaceuticals Limited 2003
GlaxoSmithKline named as India's most respected Pharmaceutical Company in a survey conducted by BusinessWorld and the Indian Market Research Bureau (IMRB) Launches Cetzine (cetirizine; anti-histamine), Zimig (terbinafine; anti-infective), CCM (calcium citrate maleate; nutritional), Cobadex CZS (multivitamin with trace elements) 2004

Augmentin becomes the No. 1 pharmaceutical brand, as rated by IMS Launches Priorix (measles, mumps, rubella vaccine)
Receives prestigious Multi Cultural Diversity Award from GlaxoSmithKline Consumer Healthcare Limited, U.S. for the Famili Vaccines programme, selected from 83 entries received from markets world-wide 2005

Foundation stone laid for GSK vaccines plant at Nashik
Launch of oral contraceptives: Elogen (desogestrel and ethinylestradiol) and Zerogen (progesterone only pill) Enters the diabetes therapeutic segment with the launch of Windia (rosiglitazone) and Windamet (rosiglitazone and metformin) 2006

Augmentin grows to a Rs. 100 crore brand
In-licensing alliance with Eisai Pharmaceuticals, Japan and launch of Parit (rabeprazole; gastrointestinal therapy area) GlaxoSmithKline divests its Agrivet Farm Care (AFC) Business 2007
Launches Carzec (carvedilol) and Zemetril (cefprozil)
GlaxoSmithKline divests its Qualigens Fine Chemicals (QFC) Business Launches Arixtra (fondaparinux sodium), an antithrombotic drug used in treating Deep Vein Thrombosis (DVT) and Acute Coronary Syndrome (ACS) 2008

Launches Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed), Infanrix (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed) and Rotarix (Human Rotavirus Vaccine, Live Attenuated) vaccines Launches Tykerb, a drug in combination with capecitabine, is indicated for the treatment of patients with advanced or metastatic breast cancer whose tumours overexpress HER2+/neu (ErbB2+) and who have failed on prior therapy including trastuzumab Launches Benitec (Olmersartan) and Benitec-H (Olmesartan + Hydrochlorothiazide) an anti-hypertensive drug in-licensed from Daiichi Sankyo Company Limited, Japan 2009

Launches Cervarix [Human Papillomavirus (Types 16 and 18)] vaccine Launches Dermocalm for treatment of Dry Itchy skin
Commences Albendazole production in Nashik to treat Lymphatic Filariasis 2010
Launches Mycamine an injectible antifungal drug in-licensed from Astellas, Japan Andrew Witty dedicates the Albendazole facility at Nashik to WHO to eliminate Lymphatic Filariasis Launches Parit D (Rabeprazole in combination with Domperidone) in-licensed from Eisai 1991...
tracking img